Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorBoston Medical Center

About this trial

Hemodialysis represents a life line of patients with end stage renal disease, who are commonly maintained on hemodialysis through catheters. Prolonged exposure to these catheters eventually damages the walls of veins, which results in stenosis at the local site. This condition is called central venous stenosis (CVS) and affects number of patients on hemodialysis in the United States and can compromise the dialysis efficacy. The current diagnostic modality for CVS is venography, which has several limitations. This study proposes to examine intravenous ultrasound (IVUS) as a potentially superior modality, which will provide additional information.

Eligibility criteria

Qualifiers

ESRD (end stage renal disease) patients at BMC (Boston Medical Center)

Receiving hemodialysis

Has a dialysis access malfunction

Undergoing a diagnostic fistulogram for the dialysis access malfunction

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Venography
  • Intravascular ultrasound (IVUS)
  • Image processing

Treatment groups

50 Participants
are divided into 1 treatment group

Sponsors and collaborators

Boston Medical Center

Lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator